If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference standard · Research use only
Co-characterized GH-axis pairing (Tesamorelin + Ipamorelin)
Price, MOQ and lead time come in your written quote — usually within 24 hours. No account needed.
Compound facts
| Name | Tesamorelin 10mg + Ipamorelin 5mg |
|---|---|
| CAS number | (blend, components have individual CAS numbers) |
| Purity specification (HPLC) | ≥ 99.0% (component-wise for blends) |
| On every batch COA | RP-HPLC purity · ESI-MS identity · Bacterial endotoxin · Fill amount (content per vial) |
| On request | LC-MS/MS sequence confirmation · Net peptide content · Water content (Karl Fischer) · Counter-ion content (e.g. acetate, TFA) · Microbial limits |
| Storage | Store cool and dry, protected from light |
| Strengths per vial | 15 mg |
| Pack | 10 vials per kit |
| MOQ | On request |
| Lead time | 14–21 days |
| Use | Research use only — not for human or veterinary use |
Identity data from the Lyochem product catalogue. The batch COA of your lot is the record for that lot's results. How to verify a COA
Lot documentation
Values belong to the lot. Ask for the COA of the offered lot before you order.
Independent test fails? Full refund. How it works
Overview
The Tesamorelin + Ipamorelin pairing combines a GHRH-receptor agonist (Tesamorelin) with a GHSR / ghrelin-receptor agonist (Ipamorelin) — the same dual-pathway architecture as the canonical CJC-1295 + Ipamorelin pairing, with Tesamorelin substituted on the GHRH arm. The two receptors converge on somatotroph signalling, which is the reason the pairing is studied together in somatotropic-axis research. The material is referenced here as a characterized pairing of two standards, not for any GH-secretion outcome. Consistent with Lyochem's methodology for multi-component systems, the two components are characterized on their own analytical packets rather than presented as a blend whose per-component data is obscured: Tesamorelin and Ipamorelin are each supplied as separately characterized lots — RP-HPLC purity (gradient method, UV 214 nm), ESI-MS identity, sequence confirmation by LC-MS/MS on request, counter-ion content, and water content by Karl Fischer — so each can be confirmed against its own standard before a lab prepares the combination in-protocol. The components carry individual CAS numbers rather than a single registered identifier for the pairing; confirm each component's API by COA / label before use. This is reference-grade research material, distinct from compounding-scale API supply.
Applications & buyer fit
GH-axis peptides ship to research labs studying somatotropic-pathway pharmacology and related models. Ask sales for the matching batch COA. Sequence, counter-ion, or stability evidence beyond that record is included only when required by a written project scope and agreed before quotation.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Every lot has its own batch-specific CoA — RP-HPLC purity, ESI-MS identity, bacterial endotoxin and fill amount, plus any analytical scope agreed at quote stage — tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Regulatory note
Components carry individual CAS numbers — confirm each component's API identity by batch COA / label before use. Lyochem supplies this pairing strictly for Research Use Only; buyers are responsible for verifying ingredient eligibility in their destination market.
Frequently asked questions
Both pair a GHRH-receptor agonist with the GHSR agonist Ipamorelin to probe the two converging arms of somatotroph signalling; the difference is the GHRH-arm molecule. Tesamorelin and CJC-1295 (no-DAC) differ in their pharmacokinetic profiles, so the two pairings are studied as related but non-identical dual-pathway reference systems. Lyochem supplies each component as an independently characterized lot in either pairing.
No. Tesamorelin and Ipamorelin are supplied as separate characterized lots, each with its own analytical packet, so a lab can confirm the identity and purity of each before preparing the combination in-protocol at its chosen ratio. A pre-mixed vial would obscure the per-component analytical data a citable methods section needs.
It is a combination of two distinct molecules, each with its own CAS Registry Number, rather than a single chemical entity. Identity is established at the component level on the applicable batch COA; buyers should confirm each component's API by COA or label rather than relying on the pairing name.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
57-mer
GHRH analog · approved for HIV-associated lipodystrophy
Also in nasal spray
Ghrelin / GHSR pathway GH-release peptide
Also in nasal spray
GH-axis blend (CJC-1295 no DAC + Ipamorelin)